Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Proteins & Antibodies

F-star and Takeda Collaborate to Pave the Way for Next-Generation Cancer Therapies  

F-star Therapeutics and Takeda are partnering to develop next-generation multi-specific antibodies for cancer immunotherapy, building on F-star's advanced platforms.
Read More
Oligonucleotides

GMP Manufacturing of LNP Formulations

Read More
Oligonucleotides

Lipids for Pharmaceutical Applications

Read More
Oligonucleotides

mRNA CDMO Services to Accelerate your mRNA Program

Read More
Oligonucleotides

Oligonucleotide Purification Solutions

Read More
Vaccines

Personalised Cancer Vaccines: Tailored Immunotherapy for Precision Treatment 

We take a look at what personalised cancer vaccines are, how they are developed, and how they are changing the field of immunotherapy.
Read More
Oligonucleotides

Rapid Analysis of mRNA 5' Capping

Read More
Oligonucleotides

Solid Phase Oligonucleotide Synthesis

Read More
Oligonucleotides

The Growing Potential for Antisense Oligonucleotide Therapy

Antisense oligonucleotides hold major promise in future patient treatment approaches. Through targeting RNA to regulate protein expression, they can help to address diseases at their source and advance therapeutic outcomes.
Read More
Biologics Analysis

Biologics Market Trends and Predictions: New Horizons Beckon

Here, we outline some of the main trends anticipated in market growth and development for biologics in the next few years. The global biologics market is predicted to exceed $600bn by 2032, driven by demand for personalised treatments for chronic diseases.
Read More
Oligonucleotides

Targeted Delivery with FORCE: Novel Approaches in Oligo Therapeutics

How are oligo therapeutics revolutionising genetic disease treatments through precise targeting and transformative therapies? In this article, we explore how they provide precise gene expression interference for untreatable conditions by directly targeting disease-associated proteins and genetic mutations.
Read More
Vaccines

How Will Commercialisation Impact COVID-19 Vaccine Prices in the US?

We take a look at how the commercialisation of COVID-19 vaccines in the US will impact the price of the vital therapeutic.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics